Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
Go back to Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring| (NASDAQ: NTRA) | Delayed: 403.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $403.95 | 52 Week High | $13.80 | |||
| Open | $403.95 | 52 Week Low | $6.52 | |||
| Day High | $403.95 | P/E | N/A | |||
| Day Low | $403.95 | EPS | $0.00 | |||
| Volume | 772 | |||||



